Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Shouming Du
CEO
sdu@brainxell.com

Message the company or request a 1:1 meeting here

BrainXell is a cash positive cell manufacturing company specializing in the production of defined, high purity, and large scale human neural cell populations. The technologies for making progenitors and mature neural cells are based on strict developmental principals, with best-in-class knowhow and methodology, backed with leading publications and patents. Our cell products and services in the preclinical market have been growing YoY and are profitable. We are now adapting our cell production technologies to a cGMP environment, where we will produce cells that can be used for Parkinson’s disease (PD) and spinal cord injury cell therapies. Our pre-IND meeting is planned for Nov 2021 and IND filing by Q4 2023 upon raising US$8M.

Pitch Video

Slide Deck

Executive Summary